Healthy Clinical Trial
— TEXTOOfficial title:
TEXTO : Total EXposure To Organic Pollutants
People are, especially in industrialized countries, exposed to a growing number of
ubiquitous chemical substances. It thus increases human exposure pathways: diet, inhalation,
soil and dust dermal contact…), notably for semi-volatile organic compounds. Diet is
generally sought to contribute the most to total exposure for many chemicals, the relative
contribution of each pathway is nevertheless poorly described, and can be different among
populations. This is in particularly the case For young children, who can be more exposed
via the environment, because of frequent contact with object and dust and hand to mouth
behaviors. Children are in addition considered more sensitive to chemical risk due to their
maturating systems.
In this context, the objective of this project is to characterize the young children's
exposure to a particular class of semi volatile organic compounds. It will encompass the
relative contribution of different pathways to the external dose, and to try to match the
internal and external doses with a physiologically based pharmacokinetic (PBPK) model for
molecules for which it is possible.
The present demand concerns a feasibility study on 2 children, for Perfluorinated Alkylated
Substances (PFAS), used in numerous consumer products.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | May 2015 |
Est. primary completion date | May 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 6 Months to 18 Months |
Eligibility |
Inclusion Criteria: Young children (2-6 months ; 12-18 months) - In outpatient pediatric or pediatric surgery ; - From their homes ; - With home located less than 30km from Rennes ; - Living at their home (not at childcare facility or child-minder); - With a scheduled blood sampling apart from this study ; - For child 2 - 6 months : - With diet exclusively based on milk (maternal exclusively or commercial exclusively) - In case of breastfeeding, with mother accepting milk sampling ; - With a free, enlightened and signed written consent from the parents. Breastfeeding mother : - > 18 years ; - Exclusive breastfeeding ; - With a free, enlightened and signed written consent. Exclusion Criteria: Children : - Metabolic illness ; - Renal or hepatic insufficiency ; - Malabsorption - With known HIV+, HBV+, HCV+, CMV+ serology - Simultaneously participating to other biomedical survey For breastfeeding mother : - Under legal protection (judicial protection, guardianship) ; - mixed breastfeeding ; - with Known HIV+, HBV+, HCV+, CMV+ serology |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
Country | Name | City | State |
---|---|---|---|
France | Rennes Hospital University | Rennes | Brittany |
Lead Sponsor | Collaborator |
---|---|
Rennes University Hospital | Agence Nationale de Sécurité Sanitaire de l'alimentation de l'Environnement et du Travail, Institut de Recherche en Santé, Environnement et le Travail, France, Institut National de l'Environnement Industriel et des Risques, Laboratoire d'Etude des Résidus et Contaminants dans les Aliments |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility recruitment | Main objective of this feasibility study is to set the scientific consortium to recruit and study 2 young children's exposures. Main judgement criteria : Effective enrolment of 2 young children during their consultation to Rennes hospital, from those having a blood sampling for medical purposes, and house survey. |
3 months | No |
Secondary | Protocol validation | Second objective is to validate protocols, procedures and methods to study exposure to PFAS. Secondary judgment criteria : Possibility to sample an extra volume of blood, to prepare it and transport it at -18°C to Laberca lab, Nantes; Possibility to organize a home visit with sampling of diet, water, air, dust and delivery of dietary questionnaire; Possibility to quantify PFAS in dietary and environmental samples; Possibility to model the internal dose for some compounds from kinetics data, and to compare doses estimated from blood measurements to those from environmental and diet measurements |
1 year | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |